Skip to main content
. 2016 Dec 28;8(4):6970–6983. doi: 10.18632/oncotarget.14344

Table 2. Relative quantification of miRNA normalized to U6snRNA in the frozen tissue and FFPE tissue of training cohort.

CRC patients with recurrence, n=14 CRC patients without recurrence, n=66 Threshold AUC
median range median range
Frozen Tissue
 let-7a 0.16 0.051 – 0.40 0.095 0.011 – 0.55 0.181 0.680
 let-7d 0.026 0.0081 – 0.069 0.015 0.0024 – 0.11 0.014 0.698
 let-7e 0.26 0.072 – 0.78 0.19 0.034 – 1.24 0.451 0.672
 miR-18b 1.7 × 10-5 0 – 4.5 × 10-4 4.6 × 10-6 0 – 1.3 × 10-4 2.7 × 10-5 0.669
 miR-23c 0.0025 1.4 × 10-4 – 0.0081 9.9 × 10-4 8.4 × 10-5 – 0.0090 0.002 0.724
 miR-26b 0.27 0.031 – 0.74 0.22 0.028 – 1.53 0.496 0.642
 miR-128a 0.018 0.0037 – 0.076 0.012 0.0010 – 0.092 0.035 0.632
 miR-146b 0.22 0.0096 – 1.21 0.22 0.026 – 0.76 0.116 0.535
 miR-148b 0.014 0.0017 – 0.070 0.0075 0.0015 – 0.033 0.007 0.686
 miR-151-5p 0.024 0.0027 – 0.17 0.017 0.0020 – 0.085 0.022 0.633
 miR-181c 0.0069 8.3 × 10-4 – 0.022 0.0042 4.4 × 10-4 – 0.032 0.007 0.729
 miR-221 0.14 0.045 – 1.08 0.11 0.018 – 0.71 0.444 0.483
 miR-222 0.40 0.075 – 1.35 0.48 0.036 – 1.19 0.791 0.462
 miR-361 0.013 0.0020 – 0.052 0.0075 8.1 × 10-4 – 0.063 0.009 0.682
 miR-500 0.0032 5.3 × 10-4 – 0.019 0.0036 2.0 × 10-4 – 0.020 0.008 0.526
FFPE tissue
 let-7a 0.23 0.096 – 0.55 0.20 0.051 – 0.68 0.245 0.542
 let-7d 0.096 0.047 – 0.21 0.75 0.021 – 0.21 0.111 0.658
 let-7e 0.31 0.16 – 0.59 0.25 0.083 – 0.63 0.303 0.618
 miR-23c 0.012 0.0033 – 0.029 0.012 0.0059 – 0.019 0.023 0.557
 miR-26b 0.21 0.10 – 0.43 0.16 0.049 – 0.43 0.174 0.668
 miR-128a 0.0090 0.0037 – 0.020 0.0076 0.0024 – 0.026 0.008 0.641
 miR-148b 0.0015 0.0059 – 0.019 0.0097 0.0029 – 0.040 0.010 0.675
 miR-151-5p 0.024 0.0072 – 0.040 0.017 3.4 × 10-5 – 0.057 0.021 0.670
 miR-181c 0.0091 0.0041 – 0.015 0.0053 0.0018 – 0.018 0.010 0.694
 miR-361 0.0093 0.0027 – 0.016 0.0071 0.0015 – 0.021 0.009 0.617

CRC: colorectal cancer, AUC: area under the curve, The thresholds were established using ROC curve and Youden index.